フルテキストファイル
著者
Komatsu, Hiroaki Department of Obstetrics and Gynecology, Japanese Red Cross Yamaguchi Hospital
Taniguchi, Fuminori Division of Reproductive-Perinatal Medicine and Gynecologic Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine 鳥取大学研究者総覧 KAKEN研究者をさがす
Harada, Takashi Division of Reproductive-Perinatal Medicine and Gynecologic Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine 鳥取大学研究者総覧 KAKEN研究者をさがす
Nakaso, Takaya Division of Reproductive-Perinatal Medicine and Gynecologic Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine
Nishimura, Noriko Department of Obstetrics and Gynecology, Japanese Red Cross Yamaguchi Hospital
Tsukihara, Satoru Department of Obstetrics and Gynecology, Japanese Red Cross Yamaguchi Hospital KAKEN研究者をさがす
Sarugami, Masako Department of Obstetrics and Gynecology, Japanese Red Cross Yamaguchi Hospital
Harada, Tasuku Division of Reproductive-Perinatal Medicine and Gynecologic Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine 鳥取大学研究者総覧 KAKEN研究者をさがす
Kanamori, Yasunobu Department of Obstetrics and Gynecology, Japanese Red Cross Yamaguchi Hospital
キーワード
premature labor
ulinastatin
urinary trypsin inhibitor
抄録
Background: We evaluated the necessity of urinary trypsin inhibitor for patients with threatened premature labor.
Methods: We enrolled 146 women with singleton pregnancies who were treated for threatened premature labor as inpatients. The uterine cervical length of each patient was ≤ 25 mm at 22–35 weeks of gestation on transvaginal ultrasonography. The patients were divided into two groups: the urinary trypsin inhibitor group (91 patients treated with urinary trypsin inhibitor daily) or non-urinary trypsin inhibitor group (55 patients not treated with urinary trypsin inhibitor). The childbirth outcomes were retrospectively assessed.
Results: The median cervical length measured on the day of admission was almost similar between the urinary trypsin inhibitor and non-urinary trypsin inhibitor groups. Depending on the symptoms of uterine contractions, we determined whether ritodrine hydrochloride and/or magnesium sulfate would be appropriate for treatment. The median gestational week at birth was 38 weeks in the urinary trypsin inhibitor group, and no obvious differences were observed when compared with the non-urinary trypsin inhibitor group. With regard to birth weight, no significant difference was found between the two groups (urinary trypsin inhibitor group, 2776 g; non-urinary trypsin inhibitor group, 2800 g).
Conclusion: Our data showed no significant beneficial effects of urinary trypsin inhibitor in the maternal course and delivery outcomes.
出版者
Tottori University Medical Press
資料タイプ
学術雑誌論文
外部リンク
ISSN・ISBN
05135710
書誌ID
AA00892882
掲載誌名
Yonago Acta Medica
最新掲載誌名
Yonago Acta Medica
62
2
開始ページ
204
終了ページ
210
発行日
2019-06-20
出版者DOI
著者版フラグ
出版社版
著作権表記
注があるものを除き、この著作物は日本国著作権法により保護されています。 / This work is protected under Japanese Copyright Law unless otherwise noted.
掲載情報
Hiroaki Komatsu, Fuminori Taniguchi, Takashi Harada, Takaya Nakaso, Noriko Nishimura, Satoru Tsukihara, Masako Sarugami, Tasuku Harada, Yasunobu Kanamori, Re-evaluation of Urinary Trypsin Inhibitor on Pregnancy Course in Patients with Threatened Preterm Delivery: A Single-Center Retrospective Study, Yonago Acta Medica, 2019, Volume 62, Issue 2, Pages 204-210
部局名
医学部・医学系研究科・医学部附属病院
言語
英語